Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. responded to criticism from some activists associated with the Make America Healthy Again movement regarding his decision to extend liability protections for drug manufacturers developing treatments for the Andes hantavirus strain. The HHS announced on May 26, 2026, that it had extended legal protections until July 18 for manufacturers and distributors of the experimental antiviral drug favipiravir as a potential treatment. Kennedy signed a declaration under the PREP Act to facilitate this extension.
✓ AI-Debiased Article
15
Public broadcaster
provisional
HHS Secretary Kennedy Responds to Criticism Over Hantavirus Treatment Protections
HHS Secretary Robert F. Kennedy Jr. addressed criticism from Make America Healthy Again activists after extending liability protections for drugmakers developing treatments for the Andes hantavirus strain. The protections for the antiviral drug favipiravir were announced on May 26, 2026, and will last until July 18.
People
Robert F. Kennedy Jr.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Kennedy faces anti-vax anger over hantavirus treatment legal protections
Neutral Headline
HHS Secretary Kennedy Responds to Criticism Over Hantavirus Treatment Protections